Wei Peng
- Molecular Biology top 10%
- Cancer Research top 2%
- Epidemiology
- Pathology and Forensic Medicine top 10%
- Plant Science
- Co-authors
- Hong FanJifeng FengJian WuWeiwei SuXuan ZengYuying ZhengZhuo WangShuangxi Zhu
- Topics
- Cancer-related molecular mechanisms research (27 papers)RNA modifications and cancer (12 papers)MicroRNA in disease regulation (8 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Peng
49 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 1.2k
- Cancer Research 977
- Epidemiology 136
- Pathology and Forensic Medicine 127
- Plant Science 108
Countries citing papers authored by Wei Peng
This map shows the geographic impact of Wei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Peng more than expected).
Fields of papers citing papers by Wei Peng
This network shows the impact of papers produced by Wei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Peng. The network helps show where Wei Peng may publish in the future.
Co-authorship network of co-authors of Wei Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Peng. A scholar is included among the top collaborators of Wei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Peng. Wei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 37 | |
| 3 | 5 | |
| 4 | 35 | |
| 5 | 9 | |
| 6 | 28 | |
| 7 | 30 | |
| 8 | 40 | |
| 9 | 35 | |
| 10 | 15 | |
| 11 | 5 | |
| 12 | 80 | |
| 13 | 19 | |
| 14 | 48 | |
| 15 | 61 | |
| 16 | 60 | |
| 17 | 43 | |
| 18 | 17 | |
| 19 | 22 | |
| 20 | Application of UPLC in orlistat purification process | 1 |
About Wei Peng
Wei Peng is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (12 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (977 citations), Molecular Biology (1.2k citations) and Biochemistry (98 citations). Wei Peng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hong Fan, Jifeng Feng, Jian Wu, Weiwei Su, Xuan Zeng, Yuying Zheng, Zhuo Wang, Shuangxi Zhu, Hongliang Yao and Guoqiu Wu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.